| ML264 |
(2E)-3-(3-氯苯基)-N-[2-[甲基(四氢-1,1-二氧代-2H-噻喃-4-基)氨基]-2-氧代乙基]-2-丙烯酰胺 |
1550008-55-3 |
| 5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]spiro[cyclobutane-1,3'-[3H]indol]-2'-amine |
A-366 |
1527503-11-2 |
| ML234 |
ML324 |
1222800-79-4 |
| LDN212854 |
(LDN212854) |
1432597-26-6 |
| FRAX1036 |
FRAX1036 |
1432908-05-8 |
| SAR 131675 |
SAR131675 |
1433953-83-3 |
| GSK 2830371 |
GSK 2830371 |
1404456-53-6 |
| Fmoc-Val-Ala-PAB-OH |
Fmoc-Val-Ala-PAB-OH |
1394238-91-5 |
| RKI1447 |
1-(3-羟基苄基)-3-(4-(吡啶-4-基)噻唑-2-基)脲 |
1342278-01-6 |
| GSK2656157 |
GSK2656157 |
1337532-29-2 |
| CEP-32496 (free base) |
CEP 32496 |
1188910-76-0 |
| (S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate |
(S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-基)乙酸叔丁酯 |
1268524-70-4 |
| 6-fluoro-N-(4-fluorobenzyl)quinazolin-4-aMine |
Spautin-1抑制剂 |
1262888-28-7 |
| 2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid |
2-[[(1R)-1-[7-甲基-2-(4-吗啉)-4-氧代-4H-吡啶并[1,2-A]嘧啶-9-基]乙基]氨基]苯甲酸 |
1173900-33-8 |
| MCB-613 |
4-乙基-2,6-双(吡啶-3-基亚甲基)环己酮 |
1162656-22-5 |
| GSK-7975A |
1253186-56-9 |
1253186-56-9 |
| QNZ-46 |
QNZ-46 |
1237744-13-6 |
| ethyl 4-(((2R,3R,4S,5R,6S)-4,5-bis(benzo[d][1,3]dioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxy-tetrahydro-2H-pyran-3-yloxy)carbonyl)benzoate |
BRD7552 |
1137359-47-7 |
| VU 0357017 hydrochloride |
VU0357017 |
1135242-13-5 |
| LY 2784544 |
LY 2784544 |
1229236-86-5 |
